Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotype-genotype correlation in Japanese patients with pachydermoperiostosis

被引:60
作者
Sasaki, Takashi [2 ,3 ]
Niizeki, Hironori [1 ]
Shimizu, Atsushi [4 ]
Shiohama, Aiko [5 ]
Hirakiyama, Asami [1 ,6 ]
Okuyama, Torayuki [6 ]
Seki, Atsuhito [7 ]
Kabashima, Kenji [8 ]
Otsuka, Atsushi [8 ]
Ishiko, Akira [9 ]
Tanese, Keiji [10 ]
Miyakawa, Shun-ichi [10 ]
Sakabe, Jun-ichi [11 ]
Kuwahara, Masamitsu [12 ]
Amagai, Masayuki [3 ]
Okano, Hideyuki [13 ]
Suematsu, Makoto [14 ]
Kudoh, Jun [5 ]
机构
[1] Natl Ctr Child Hlth & Dev, Dept Dermatol, Setagaya Ku, Tokyo 1578535, Japan
[2] Keio Univ, Sch Med, Ctr Integrated Med Res, Shinjuku Ku, Tokyo, Japan
[3] Keio Univ, Sch Med, Dept Dermatol, Shinjuku Ku, Tokyo, Japan
[4] Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo, Japan
[5] Keio Univ, Sch Med, Lab Gene Med, Shinjuku Ku, Tokyo, Japan
[6] Natl Ctr Child Hlth & Dev, Dept Lab Med, Setagaya Ku, Tokyo 1578535, Japan
[7] Natl Ctr Child Hlth & Dev, Dept Orthoped, Setagaya Ku, Tokyo 1578535, Japan
[8] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan
[9] Toho Univ, Sch Med, Dept Dermatol 1, Ota Ku, Tokyo, Japan
[10] Kawasaki Municipal Hosp, Div Dermatol, Kawasaki, Kanagawa, Japan
[11] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4312102, Japan
[12] Nara Med Univ, Div Plast Surg, Kashihara, Nara 634, Japan
[13] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo, Japan
[14] Keio Univ, Sch Med, Dept Biochem, Shinjuku Ku, Tokyo, Japan
关键词
PDP; Whole exome sequencing; Mutation analysis; SLCO2A1; Prostaglandin transporter; PRIMARY HYPERTROPHIC OSTEOARTHROPATHY; HPGD MUTATIONS;
D O I
10.1016/j.jdermsci.2012.07.008
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Pachydermoperiostosis (PDP) is a rare genetic disorder characterized by 3 major symptoms: pachydermia including cutis verticis gyrata (CVG), periostosis, and finger clubbing. Recently, a homozygous mutation in the gene HPGD, which encodes 15-hydroxyprostaglandin dehydrogenase (15-PGDH), was found to be associated with PDP. However, mutations in HPGD have not been identified in Japanese PDP patients. Objective: We aimed to identify a novel responsible gene for PDP using whole exome sequencing by next-generation DNA sequencer (NGS). Methods: Five patients, including 2 patient-parent trios were enrolled in this study. Entire coding regions were sequenced by NGS to identify candidate mutations associated with PDP. The candidate mutations were subsequently sequenced using the Sanger method. To determine clinical characteristics, we analyzed histological samples, as well as serum and urinary prostaglandin E2 (PGE2) levels for each of the 5 PDP patients, and 1 additional patient with idiopathic CVG. Results: From initial analyses of whole exome sequencing data, we identified mutations in the solute carrier organic anion transporter family, member 2A1 (SLCO2A1) gene, encoding prostaglandin transporter, in 3 of the POP patients. Follow-up Sanger sequencing showed 5 different SLCO2A1 mutations (c.940+1G > A, p.E427_P430del, p.G104*, p.T3471, p.Q556H) in 4 unrelated PDP patients. In addition, the splice-site mutation c.940+1G > A identified in 3 of 4 PDP patients was determined to be founder mutation in the Japanese population. Furthermore, it is likely that the combination of these SLCO2A1 mutations in PDP patients is also associated with disease severity. Conclusion: We found that SLCO2A1 is a novel gene responsible for PDP. Although the SLCO2A1 gene is only the second gene discovered to be associated with PDP, it is likely to be a major cause of PDP in the Japanese population. (c) 2012 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:36 / 44
页数:9
相关论文
共 24 条
  • [21] Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy
    Uppal, Sandeep
    Diggle, Christine P.
    Carr, Ian M.
    Fishwick, Colin W. G.
    Ahmed, Mushtaq
    Ibrahim, Gamal H.
    Helliwell, Philip S.
    Latos-Bielenska, Anna
    Phillips, Simon E. V.
    Markham, Alexander F.
    Bennett, Christopher P.
    Bonthron, David T.
    [J]. NATURE GENETICS, 2008, 40 (06) : 789 - 793
  • [22] Differential effects of prostaglandin E2 and enamel matrix derivative on the proliferation of human gingival and dermal fibroblasts and gingival keratinocytes
    Weinberg, E.
    Topaz, M.
    Dard, M.
    Lyngstadaas, P.
    Nemcovsky, C.
    Weinreb, M.
    [J]. JOURNAL OF PERIODONTAL RESEARCH, 2010, 45 (06) : 731 - 740
  • [23] Homozygous mutations in the 15-hydroxyprostaglandin dehydrogenase gene in patients with primary hypertrophic osteoarthropathy
    Yuksel-Konuk, Berrin
    Sirmaci, Asli
    Ayten, Guelen Ece
    Ozdemir, Mustafa
    Aslan, Idil
    Yilmaz-Turay, Uelkue
    Erdogan, Yurdanur
    Tekin, Mustafa
    [J]. RHEUMATOLOGY INTERNATIONAL, 2009, 30 (01) : 39 - 43
  • [24] Exome Sequencing Identifies SLCO2A1 Mutations as a Cause of Primary Hypertrophic Osteoarthropathy
    Zhang, Zhenlin
    Xia, Weibo
    He, Jinwei
    Zhang, Zeng
    Ke, Yaohua
    Yue, Hua
    Wang, Chun
    Zhang, Hao
    Gu, Jiemei
    Hu, Weiwei
    Fu, Wenzhen
    Hu, Yunqiu
    Li, Miao
    Liu, Yujuan
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2012, 90 (01) : 125 - 132